5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 42.50▲ | 42.11▲ | 42.12▲ | 40.49▲ | 43.64▼ |
MA10 | 42.35▲ | 42.06▲ | 41.92▲ | 41.19▲ | 44.44▼ |
MA20 | 42.12▲ | 41.79▲ | 41.39▲ | 42.98▼ | 37.61▲ |
MA50 | 42.05▲ | 40.84▲ | 40.35▲ | 44.72▼ | 40.03▲ |
MA100 | 41.93▲ | 40.36▲ | 41.82▲ | 37.28▲ | 35.73▲ |
MA200 | 41.37▲ | 42.09▲ | 43.62▼ | 38.94▲ | 33.80▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.066▲ | 0.000▲ | 0.115▲ | -0.175▼ | 0.547▲ |
RSI | 75.688▲ | 67.185▲ | 67.456▲ | 49.945▼ | 54.391▲ |
STOCH | 93.699▲ | 50.730 | 77.042 | 47.305 | 57.462 |
WILL %R | -3.125▲ | -1.953▲ | -1.020▲ | -27.865 | -34.399 |
CCI | 105.187▲ | 182.765▲ | 111.900▲ | 21.152 | -10.958 |
Wednesday, August 13, 2025 05:20 AM
Q2 2025 Earnings Call Transcript August 11, 2025 Kymera Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.95 EPS, expectations were $-0.83. Operator: Good day, everyone. My name ...
|
Tuesday, August 12, 2025 12:06 AM
Kymera Therapeutics Inc (KYMR) extends cash runway into 2028, bolstered by key partnerships with Gilead and Sanofi, despite facing high R&D expenses and revenue challenges.
|
Monday, August 11, 2025 10:27 AM
Kymera Therapeutics' Q2 2025 earnings call highlights clinical progress, Gilead and Sanofi partnerships, and financial strength, setting a strong stage ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 41.82 | 42.66 | 41.70 | 42.63 | 824,527 |
14/08/25 | 40.18 | 41.84 | 40.005 | 41.55 | 814,325 |
13/08/25 | 40.38 | 41.81 | 39.7131 | 40.73 | 831,580 |
12/08/25 | 37.82 | 40.00 | 37.57 | 39.87 | 939,797 |
11/08/25 | 38.16 | 40.09 | 36.65 | 37.68 | 1,736,904 |
08/08/25 | 40.67 | 40.91 | 39.54 | 40.62 | 840,550 |
07/08/25 | 41.53 | 41.53 | 40.31 | 40.85 | 540,190 |
06/08/25 | 42.60 | 42.835 | 40.44 | 41.35 | 556,976 |
05/08/25 | 43.79 | 43.79 | 42.43 | 42.97 | 297,562 |
04/08/25 | 43.03 | 43.84 | 42.57 | 43.66 | 379,788 |
|
|
||||
|
|
||||
|
|